GlassScriptPhysician profile
Traci Blackburn
NPI 1295586196
$842.81
in general payments reported to CMS, 2019-2025
19 companies · $843 in 2025
The $843 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $153.15 | 2025 | Padcev, Vyloy |
| Abbvie INC. | $105.36 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $72.11 | 2025 | |
| Tersera Therapeutics LLC | $64.37 | 2025 | Xermelo |
| Merck Sharp & Dohme LLC | $60.59 | 2025 | Reblozyl, Welireg, Keytruda Qlex |
| Janssen Biotech, INC. | $55.65 | 2025 | Erleada, Akeega, Darzalex |
| Bayer Healthcare Pharmaceuticals INC. | $55.58 | 2025 | |
| Aveo Pharmaceuticals, INC. | $39.88 | 2025 | |
| Novartis Pharmaceuticals Corporation | $29.35 | 2025 | |
| Fresenius Kabi USA, LLC | $26.61 | 2025 | |
| Nuvation Bio INC. | $22.86 | 2025 | Ibtrozi |
| Emd Serono, INC. | $22.50 | 2025 | |
| Rigel Pharmaceuticals, INC. | $22.13 | 2025 | Gavreto, Tavalisse, Rezlidhia |
| Pharmaessentia USA Corporation | $20.70 | 2025 | Besremi |
| Eisai INC. | $20.54 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $18.44 | 2025 | |
| Caris Mpi, INC. | $18.13 | 2025 | Mi Cancer Seek |
| Alnylam Pharmaceuticals INC. | $17.70 | 2025 | Onpattro |
| Invivyd INC | $17.16 | 2025 | Pemgarda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Blackburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.